Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |